Cleara Biotech Competitors and Similar CompaniesClear all
Cleara Biotech's competitors and similar companies include ARIAD Pharmaceuticals, HUYA Bioscience International, Replimune and Carna Biosciences.
 Cleara Biotech Cleara Biotech is a company engaged in the creation of therapeutics targeting age-related pathologies and therapy-resistant cancer. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Carna Biosciences Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. | ||
Founding Date | Founding Date 2018 | Founding Date 1991 | Founding Date 2004 | Founding Date 2015 | Founding Date 2003 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Utrecht, NL HQ | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Kobe, JP HQ Natick, US |
Employees | Employees 147% decrease | Employees 1381% increase | Employees 1113% increase | Employees 10422% increase | Employees 65 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 823.3 m | Valuation ($) 38.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥579.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.1m (FY, 2015) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥190.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $116.7m (FY, 2015) | Gross profit N/A | Gross profit N/A | Gross profit ¥388.1m (FY, 2025) |
Net income | Net income N/A | Net income ($231.2m) (FY, 2015) | Net income N/A | Net income ($247.3m) (FY, 2025) | Net income (¥2.2b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised $ 30m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View company
Replimune
HQ
Woburn, US
Employees
104↑ 22% increase
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyCarna Biosciences
HQ
Kobe, JP
Employees
65
Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services.
View company